病毒过滤市场规模、份额、成长分析（按产品、应用、最终用户、地区）- 产业预测，2025 年至 2032 年

全球病毒过滤市场规模预计在 2023 年达到 53 亿美元，到 2032 年将达到 128.1 亿美元，预计在预测期内（2025-2032 年）的复合年增长率为 10.3%。

全球病毒过滤市场正在经历显着增长，这得益于对需要严格病毒安全通讯协定的生技药品的需求不断增长。随着生物製药公司专注于开发先进的治疗方法，病毒过滤在确保产品纯度方面发挥关键作用，尤其是在单株抗体和重组蛋白中。不断增加的研发投入和政府的支持政策也在增强生物製造能力。一个值得注意的趋势是注重技术创新，主要企业都在投资下一代薄膜技术和一次性过滤系统，以提高吞吐量并最大限度地降低污染风险。市场正在扩展到医疗设备、水处理和空气净化应用领域。过滤的自动化以及製造商和生物加工公司之间的策略联盟正在进一步加速客製化解决方案和验证通讯协定的开发。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究

病毒过滤市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 套件和试剂
• 过滤系统
• 服务
• 其他产品

病毒过滤市场规模（按应用划分）及复合年增长率（2025-2032）

• 市场概览
• 生技药品
  • 疫苗和治疗
  • 血液和血液製品
  • 细胞和基因疗法产品
  • 纸巾及纸巾製品
  • 干细胞产品
• 医疗设备
• 水净化
• 空气净化

病毒过滤市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 製药和生物技术公司
• 合约研究组织
• 学术研究所
• 医疗设备公司

病毒过滤市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Merck KGaA
• Danaher
• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE HealthCare
• Charles River Laboratories
• Asahi Kasei Medical Co., Ltd.
• Sartorius AG
• Lonza
• Sigma-Aldrich Corporation
• Clean Biologics

结论和建议

Global Virus Filtration Market size was valued at USD 5.3 billion in 2023 and is poised to grow from USD 5.85 billion in 2024 to USD 12.81 billion by 2032, growing at a CAGR of 10.3% during the forecast period (2025-2032).

The global virus filtration market is experiencing significant growth, driven by the rising demand for biologics that require stringent viral safety protocols. As biopharmaceutical companies focus on developing advanced therapies, virus filtration plays a crucial role in ensuring product purity, especially for monoclonal antibodies and recombinant proteins. Increased R&D investments and supportive government initiatives are also enhancing biomanufacturing capabilities. A notable trend is the focus on technological innovation, with key players investing in next-generation membrane technologies and single-use filter systems that improve throughput and minimize contamination risks. The market is expanding into medical devices, water treatment, and air purification applications. Automation of filtration processes and strategic collaborations between manufacturers and bioprocessing firms further accelerate the development of tailored solutions and validation protocols.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Virus Filtration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Virus Filtration Market Segments Analysis

Global Virus Filtration Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Kits and Reagents, Filtration Systems, Services and Other Products. Based on Application, the market is segmented into Biologicals, Medical Devices, Water Purification and Air Purification. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic Research Institutes and Medical Device Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Virus Filtration Market

The global virus filtration market is experiencing significant growth driven by the increasing adoption of biologic therapies and mRNA-based vaccines. As biopharmaceutical and biomanufacturing companies embark on developing innovative treatments such as monoclonal antibodies, recombinant proteins, and gene therapies, the necessity for stringent viral safety measures throughout the manufacturing process has become paramount. This heightened focus on viral safety stems from the rapid expansion of biologic pipelines, compelling manufacturers to invest in effective virus-removal filters to adhere to stringent purity regulations. Consequently, the demand for advanced virus filtration systems is closely linked to the overall growth of biological production on a global scale.

Restraints in the Global Virus Filtration Market

The global virus filtration market faces significant constraints due to the high initial capital costs associated with emerging virus filtration technologies, such as single-use systems or nanofiber membranes. Smaller and mid-sized biopharmaceutical companies often struggle to allocate budgets for expensive capital equipment, custom consumables, and the necessary skilled personnel. Moreover, the considerable operating expenses linked to routine filter replacements and validation studies can deter these companies from making investments in new technologies. This is particularly pronounced in developing markets, where funding limitations can hinder the acquisition of advanced sterilizing filtration systems, ultimately stalling progress in the adoption of innovative filtration solutions.

Market Trends of the Global Virus Filtration Market

The Global Virus Filtration market is witnessing a significant shift towards single-use and continuous bioprocessing platforms, driven by manufacturers seeking enhanced efficiency and safety in downstream purification processes. Single-use filtration systems minimize the risk of cross-contamination, reduce changeover times, and eliminate the necessity for extensive cleaning-validated procedures, making them particularly attractive for multiproduct facilities. Furthermore, continuous bioprocessing enhances productivity by allowing for seamless viral-clearance steps, thus increasing throughput while ensuring robust viral safety measures. This trend towards modular, disposable units aligns with the industry's flexibility objectives, enabling quick deployment and reconfiguration in response to fluctuating production demands, ultimately accelerating time-to-market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies

Global Virus Filtration Market Size by Product & CAGR (2025-2032)

• Market Overview
• Kits and Reagents
• Filtration Systems
• Services
• Other Products

Global Virus Filtration Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biologicals
  • Vaccines and Therapeutics
  • Blood and Blood Products
  • Cellular and Gene Therapy Products
  • Tissue and Tissue Products
  • Stem Cell Products
• Medical Devices
• Water Purification
• Air Purification

Global Virus Filtration Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Medical Device Companies

Global Virus Filtration Market Size & CAGR (2025-2032)

• North America (Product, Application, End User)
  • US
  • Canada
• Europe (Product, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clean Biologics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations